{"id":"https://openalex.org/W2594449800","doi":"https://doi.org/10.1182/blood.v116.21.134.134","title":"Biology and Therapeutic Targeting of Sp1 Transactivation In Myeloma","display_name":"Biology and Therapeutic Targeting of Sp1 Transactivation In Myeloma","publication_year":2010,"publication_date":"2010-11-19","ids":{"openalex":"https://openalex.org/W2594449800","doi":"https://doi.org/10.1182/blood.v116.21.134.134","mag":"2594449800"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v116.21.134.134","doi":"https://doi.org/10.1182/blood.v116.21.134.134","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v116.21.134.134","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5062468245","display_name":"Mariateresa Fulciniti","orcid":"https://orcid.org/0000-0002-1432-9742","observed_orcids":["https://orcid.org/0000-0002-1432-9742"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Mariateresa Fulciniti","raw_affiliation_strings":["Dana Farber Cancer Institute, Boston, MA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana Farber Cancer Institute, Boston, MA, USA,","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057939952","display_name":"Samirkumar B. Amin","orcid":"https://orcid.org/0000-0002-3207-9505","observed_orcids":["https://orcid.org/0000-0002-3207-9505"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Samir B. Amin","raw_affiliation_strings":["Dana Farber Cancer Institute, Boston, MA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana Farber Cancer Institute, Boston, MA, USA,","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017577287","display_name":"Puru Nanjappa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Puru Nanjappa","raw_affiliation_strings":["Dana Farber Cancer Institute, Boston, MA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana Farber Cancer Institute, Boston, MA, USA,","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058975989","display_name":"Scott J. Rodig","orcid":"https://orcid.org/0000-0003-1761-9769","observed_orcids":["https://orcid.org/0000-0003-1761-9769"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Scott J Rodig","raw_affiliation_strings":["Brigham & Women's Hospital, Boston, MA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Brigham & Women's Hospital, Boston, MA, USA,","institution_ids":["https://openalex.org/I1283280774"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091207345","display_name":"Teru Hideshima","orcid":"https://orcid.org/0000-0003-2939-6224","observed_orcids":["https://orcid.org/0000-0003-2939-6224"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Teru Hideshima","raw_affiliation_strings":["Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA,","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040654673","display_name":"Jagannath Pal","orcid":"https://orcid.org/0000-0002-7110-4048","observed_orcids":["https://orcid.org/0000-0002-7110-4048"]},"institutions":[{"id":"https://openalex.org/I2801671727","display_name":"VA Boston Healthcare System","ror":"https://ror.org/04v00sg98","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I2801671727","https://openalex.org/I4210095851"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Jagannath Pal","raw_affiliation_strings":["Dana-Farber Cancer Institute; VA Boston Healthcare System, Boston, MA, USA,","Dana-Farber Cancer Institute"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute; VA Boston Healthcare System, Boston, MA, USA,","institution_ids":["https://openalex.org/I2801671727","https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Dana-Farber Cancer Institute","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085211625","display_name":"Varuna Mohan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Varuna Mohan","raw_affiliation_strings":["Dana Farber Cancer Institute, Boston, MA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana Farber Cancer Institute, Boston, MA, USA,","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079704685","display_name":"Keeyun Lee","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Keeyun Lee","raw_affiliation_strings":["Dana Farber Cancer Institute, Boston, MA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana Farber Cancer Institute, Boston, MA, USA,","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063099799","display_name":"Masood A. Shammas","orcid":"https://orcid.org/0000-0002-8932-6829","observed_orcids":["https://orcid.org/0000-0002-8932-6829"]},"institutions":[{"id":"https://openalex.org/I2801671727","display_name":"VA Boston Healthcare System","ror":"https://ror.org/04v00sg98","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I2801671727","https://openalex.org/I4210095851"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Masood Shammas","raw_affiliation_strings":["Dana-Farber Cancer Institute; VA Boston Healthcare System, Boston, MA, USA,","Dana-Farber Cancer Institute"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute; VA Boston Healthcare System, Boston, MA, USA,","institution_ids":["https://openalex.org/I2801671727","https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Dana-Farber Cancer Institute","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073612758","display_name":"St\u00e9phane Minvielle","orcid":"https://orcid.org/0000-0003-1389-312X","observed_orcids":["https://orcid.org/0000-0003-1389-312X"]},"institutions":[{"id":"https://openalex.org/I97188460","display_name":"Nantes Universit\u00e9","ror":"https://ror.org/03gnr7b55","country_code":"FR","type":"education","lineage":["https://openalex.org/I97188460"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Stephane Minvielle","raw_affiliation_strings":["U, Nantes, France,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"U, Nantes, France,","institution_ids":["https://openalex.org/I97188460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056254084","display_name":"RAO H. PRABHALA","orcid":"https://orcid.org/0000-0002-6375-0437","observed_orcids":["https://orcid.org/0000-0002-6375-0437"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Rao Prabhala","raw_affiliation_strings":["Dana Farber Cancer Institute, Boston, MA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana Farber Cancer Institute, Boston, MA, USA,","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063422967","display_name":"Herv\u00e9 Avet\u2010Loiseau","orcid":"https://orcid.org/0000-0002-3050-0140","observed_orcids":["https://orcid.org/0000-0002-3050-0140"]},"institutions":[{"id":"https://openalex.org/I3019204325","display_name":"Centre Hospitalier Universitaire de Nantes","ror":"https://ror.org/05c1qsg97","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019204325"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Herve\u0301 Avet-Loiseau","raw_affiliation_strings":["University Hospital of Nantes, Nantes, France,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Hospital of Nantes, Nantes, France,","institution_ids":["https://openalex.org/I3019204325"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038883988","display_name":"Li Cheng","orcid":"https://orcid.org/0000-0001-5173-5056","observed_orcids":["https://orcid.org/0000-0001-5173-5056"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Li Cheng","raw_affiliation_strings":["Dana Farber Cancer Institute, Boston, MA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana Farber Cancer Institute, Boston, MA, USA,","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032464400","display_name":"Kenneth Carl Anderson","orcid":"https://orcid.org/0000-0002-6418-0886","observed_orcids":["https://orcid.org/0000-0002-6418-0886"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kenneth C. Anderson","raw_affiliation_strings":["Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA,","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5045740077","display_name":"Nikhil C. Munshi","orcid":"https://orcid.org/0000-0002-7344-9795","observed_orcids":["https://orcid.org/0000-0002-7344-9795","https://orcid.org/0000-0002-8397-100X"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I2801671727","display_name":"VA Boston Healthcare System","ror":"https://ror.org/04v00sg98","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I2801671727","https://openalex.org/I4210095851"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nikhil C. Munshi","raw_affiliation_strings":["Dana-Farber Cancer Institute; VA Boston Healthcare System and Harvard Medical School, Boston, MA, USA","Dana-Farber Cancer Institute"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute; VA Boston Healthcare System and Harvard Medical School, Boston, MA, USA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I2801671727","https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Dana-Farber Cancer Institute","institution_ids":["https://openalex.org/I4210117453"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5017577287","https://openalex.org/A5038883988","https://openalex.org/A5040654673","https://openalex.org/A5056254084","https://openalex.org/A5062468245","https://openalex.org/A5063099799","https://openalex.org/A5073612758","https://openalex.org/A5079704685","https://openalex.org/A5085211625"],"corresponding_institution_ids":["https://openalex.org/I2801671727","https://openalex.org/I4210117453","https://openalex.org/I97188460"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.38748,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"116","issue":"21","first_page":"134","last_page":"134"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sp1","display_name":"Sp1","score":0.9459999799728394},{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.9959999918937683},{"id":"https://openalex.org/keywords/tmp","display_name":"TMP","score":0.4950000047683716},{"id":"https://openalex.org/keywords/erk-signaling","display_name":"ERK signaling","score":0.7860000133514404},{"id":"https://openalex.org/keywords/lenalidomide-resistance","display_name":"lenalidomide resistance","score":0.8420000076293945},{"id":"https://openalex.org/keywords/dexamethasone-resistance","display_name":"dexamethasone resistance","score":0.9950000047683716},{"id":"https://openalex.org/keywords/mitochondrial-apoptosis","display_name":"mitochondrial apoptosis","score":0.5830000042915344},{"id":"https://openalex.org/keywords/caspase-activation","display_name":"caspase activation","score":0.9150000214576721},{"id":"https://openalex.org/keywords/hif-1alpha","display_name":"HIF-1\u03b1","score":0.722000002861023},{"id":"https://openalex.org/keywords/hdac1","display_name":"HDAC1","score":0.9359999895095825},{"id":"https://openalex.org/keywords/mapk-genes","display_name":"MAPK genes","score":0.8669999837875366}],"concepts":[{"id":"https://openalex.org/C1292079","wikidata":"https://www.wikidata.org/wiki/Q3817769","display_name":"Transactivation","level":4,"score":0.8214309811592102},{"id":"https://openalex.org/C57467964","wikidata":"https://www.wikidata.org/wiki/Q14888082","display_name":"Sp1 transcription factor","level":5,"score":0.7481329441070557},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5937588214874268},{"id":"https://openalex.org/C86339819","wikidata":"https://www.wikidata.org/wiki/Q407384","display_name":"Transcription factor","level":3,"score":0.5206034183502197},{"id":"https://openalex.org/C190232843","wikidata":"https://www.wikidata.org/wiki/Q1950808","display_name":"Small hairpin RNA","level":4,"score":0.4980020523071289},{"id":"https://openalex.org/C57074206","wikidata":"https://www.wikidata.org/wiki/Q14197552","display_name":"MAPK/ERK pathway","level":3,"score":0.492861270904541},{"id":"https://openalex.org/C111335760","wikidata":"https://www.wikidata.org/wiki/Q95385166","display_name":"Luciferase","level":4,"score":0.4669082760810852},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.4421866834163666},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4390646815299988},{"id":"https://openalex.org/C2780538058","wikidata":"https://www.wikidata.org/wiki/Q17917642","display_name":"ETS1","level":4,"score":0.4348498582839966},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.41680243611335754},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.41499656438827515},{"id":"https://openalex.org/C101762097","wikidata":"https://www.wikidata.org/wiki/Q224093","display_name":"Promoter","level":4,"score":0.4046749472618103},{"id":"https://openalex.org/C54009773","wikidata":"https://www.wikidata.org/wiki/Q1429031","display_name":"Transfection","level":3,"score":0.39200109243392944},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.38557347655296326},{"id":"https://openalex.org/C173396325","wikidata":"https://www.wikidata.org/wiki/Q1501275","display_name":"Gene knockdown","level":3,"score":0.3630565404891968},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.3365684747695923},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.25937068462371826},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.2180841863155365},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.16918325424194336}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v116.21.134.134","doi":"https://doi.org/10.1182/blood.v116.21.134.134","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v116.21.134.134","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2135117774","https://openalex.org/W2588913772","https://openalex.org/W2548281283","https://openalex.org/W2592465236","https://openalex.org/W2974055316","https://openalex.org/W2979710439","https://openalex.org/W2047910134","https://openalex.org/W3017907098","https://openalex.org/W2399914760","https://openalex.org/W2316236866"],"abstract_inverted_index":{"Abstract":[0,1],"134":[2],"Alteration":[3],"in":[4,42,57,71,156,176,187,197,237,243,258,261,263,376,394,408,425],"expression":[5,141],"and":[6,23,46,63,120,130,169,218,234,260,315,317,340,370,399],"function":[7],"of":[8,34,133,143,163,185,205,230,246,252,266,271,293,296,303,312,330,392,416,435,446,459],"transcription":[9,29],"factors":[10],"has":[11],"been":[12],"frequently":[13],"associated":[14],"with":[15,173,250,284,289,328,402],"neoplastic":[16],"transformation.":[17],"We":[18,65,199,224,298,334,354],"here":[19],"provide":[20],"both":[21,61,74,118,231,257],"experimental":[22],"clinical":[24,179,406],"evidence":[25],"that":[26,31,161,338,346,357,413],"Sp1,":[27],"a":[28,203,350],"factor":[30],"controls":[32],"number":[33],"cellular":[35],"processes,":[36],"plays":[37],"an":[38,421,432,443,456],"important":[39,422],"regulatory":[40],"role":[41,184,391],"MM":[43,58,72,92,136,144,188,238,281,377,384],"cell":[44,137,378,396],"growth":[45,129],"survival.":[47],"Although":[48],"Sp1":[49,69,97,123,134,186,196,217,222,232,253,285,343,347,360,393,417],"is":[50,59,366],"ubiquitously":[51],"expressed,":[52],"its":[53,403],"nuclear":[54],"localization":[55],"observed":[56,256,301,337],"functionally":[60],"relevant":[62],"important.":[64],"have":[66,126,152,200,225,299,335,355],"confirmed":[67,127,154,227,356],"high":[68],"activity":[70,86,236,361,418],"cells":[73,145,239,282],"by":[75,88,103,111,159,240,308,362,368],"demonstrating":[76],"increased":[77,83,359],"DNA":[78],"binding":[79,233],"as":[80,82,380,382],"well":[81,381],"Sp1-responsive":[84],"promoter":[85],"measured":[87],"luciferase":[89],"reporter":[90],"assay.":[91],"cell-BMSC":[93],"interaction":[94,215],"led":[95],"to":[96,193],"activation":[98,302,311],"which":[99,212],"was":[100,275,322],"completely":[101],"abrogated":[102,367],"the":[104,112,128,183,191,206,214,244,304,358,371],"ERK":[105],"pathway":[106,307],"inhibitor":[107,114],"U0126":[108],"but":[109],"not":[110,323],"AKT":[113],"LY29004.":[115],"Furthermore,":[116],"using":[117],"SiRNA":[119],"ShRNA":[121],"mediated":[122],"knock-down,":[124],"we":[125,151,255,388],"survival":[131,398],"effects":[132],"on":[135,405,431,442,455],"growth.":[138],"Using":[139],"gene":[140],"profile":[142],"from":[146],"172":[147],"uniformly":[148],"treated":[149,288],"patients,":[150],"further":[153,181,300],"these":[155],"vitro":[157,259],"results":[158,411],"observing":[160],"overexpression":[162],"Sp1-related":[164],"genes,":[165,171],"including":[166,242],"HIF-1a,":[167],"HDAC1":[168],"MAPK":[170],"correlate":[172],"poor":[174],"prognosis":[175],"MM.":[177,198,409,426],"This":[178],"correlation":[180],"suggests":[182],"biology,":[189],"providing":[190],"rationale":[192],"preclinically":[194],"target":[195,424],"investigated":[201],"TMP,":[202,241,290],"derivative":[204],"plant":[207],"lignan":[208],"nordihydroguaiaretic":[209],"acid":[210],"(NDGA)":[211],"disrupts":[213],"between":[216],"GC-rich":[219],"motifs":[220],"inhibiting":[221],"activity.":[223],"previously":[226],"specific":[228,414],"inhibition":[229,251,415],"transcriptional":[235],"context":[245],"MM-BMSC":[247],"interaction.":[248],"Along":[249],"activity,":[254,344],"vivo":[262],"murine":[264],"models":[265],"human":[267],"myeloma,":[268],"anti-myeloma":[269],"effect":[270,279],"TMP.":[272],"Importantly,":[273],"there":[274],"no":[276],"significant":[277,390],"synergistic":[278,374],"when":[280],"transfected":[283],"siRNA":[286],"were":[287],"confirming":[291],"specificity":[292],"TMP's":[294],"mechanism":[295],"action.":[297],"mitochondrial":[305],"apoptotic":[306,332],"TMP":[309,369],"via":[310],"caspase-3,":[313],"-9":[314],"-7":[316],"PARP":[318],"cleavage":[319],"while":[320],"caspase-8":[321],"activated":[324],"suggesting":[325,345],"possible":[326],"synergism":[327],"activators":[329],"alternate":[331],"pathways.":[333],"also":[336],"lenalidomide":[339,363],"dexamethasone":[341,365],"upregulate":[342],"may":[348,419],"be":[349,420],"common":[351],"resistance":[352,401],"mechanism.":[353],"or":[364,437,448,461],"combination":[372],"provides":[373],"cytotoxicity,":[375],"lines":[379],"primary":[383],"cells.":[385],"In":[386],"conclusion,":[387],"report":[389],"myeloma":[395],"growth,":[397],"drug":[400],"influence":[404],"outcome":[407],"Our":[410],"suggest":[412],"therapeutic":[423],"Disclosures:":[427],"Avet-Loiseau:":[428],"Celgene:":[429],"Membership":[430,441,454],"entity's":[433,444,457],"Board":[434,445,458],"Directors":[436,447,460],"advisory":[438,449,462],"committees;":[439],"Janssen-Cilag:":[440],"committees.":[450],"Anderson:Millennium":[451],"Pharmaceuticals:":[452,469],"Honoraria,":[453,470],"committees,":[463],"Research":[464],"Funding,":[465],"Speakers":[466,471],"Bureau.":[467,472],"Munshi:Millennium":[468]},"counts_by_year":[],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2017-03-16T00:00:00"}